Esperion Therapeutics
ESPR
#7380
Rank
C$0.51 B
Marketcap
$2.64
Share price
-0.53%
Change (1 day)
-26.36%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2024 (TTM): -C$38.66 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are C$0.29 Billion. In 2023 the company made an earning of -C$0.22 Billion, an increase over its 2022 earnings that were of -C$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$38.66 Million-81.86%
2023 -C$0.22 Billion-15.03%
2022 -C$0.26 Billion-20.61%
2021 -C$0.32 Billion84.28%
2020 -C$0.18 Billion35.75%
2019 -C$0.13 Billion-55.71%
2018 -C$0.29 Billion19.57%
2017 -C$0.24 Billion125.39%
2016 -C$0.11 Billion51.43%
2015 -C$69.87 Million36.45%
2014 -C$51.21 Million43.55%
2013 -C$35.67 Million145.26%
2012 -C$14.55 Million
2002 -C$41.47 Million-7.81%
2001 -C$44.98 Million15.03%
2000 -C$39.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.71 Billion 1,617.94%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.55 B-1,455.21%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.84 B-24,136.70%๐Ÿ‡บ๐Ÿ‡ธ USA
C$7.04 B-17,304.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$96.93 Million 136.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.31 Billion 649.15%๐Ÿ‡บ๐Ÿ‡ธ USA